Graeme J. Moyle

Corporate Officer/Principal presso Chelsea & Westminster Hospital

60 anni

Health Technology

Consumer Services

Posizioni attive di Graeme J. Moyle

Società	Posizione	Inizio	Fine
Chelsea & Westminster Hospital	Corporate Officer/Principal	01/01/1994	-

Società	Posizione	Inizio	Fine
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Direttore/Membro del Consiglio	23/06/2014	-
	Independent Dir/Board Member	23/06/2014	-

University of Adelaide

Doctorate Degree

Distribuzione geografica

Posizioni

Director/Board Member	1
Independent Dir/Board Member	1
Doctorate Degree	1

Settori

Health Technology	2
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Health Technology
Chelsea & Westminster Hospital

Aziende private

Health Technology

Chelsea & Westminster Hospital